THE AMERICAN ASSOCIATION of
AACE Annual Scientific
CLINICAL ENDOCRINOLOGISTS
& Clinical Congress

WEDNESDAY, May 25 |
|
6:30 am – 6:30 pm |
Registration |
12:30 pm – 6:30 pm |
CME Station Hours |
8:00 am – 12:00 pm |
Pre Congress Session I |
|
W11: Diabetes Technology 2016
Room: Suwannee 16/17 |
|
W21: Inpatient Endocrinology Part 1: Diabetes and Nutrition
Room: Suwannee 11/12 |
|
W31: Cardiovascular Medicine for the Endocrinologist
Room: Suwannee 18/19 |
|
Room: Suwanee 20/21 |
1:00 pm – 5:00 pm |
W12: Inpatient Endocrinology Part 2: What an Endocrinologist Needs to Know About Surgery and What a Surgeon Needs to Know About Endocrinology
Pituitary and Adrenal Session
|
|
W22: The Practice of Obesity Medicine in 2016
|
|
W32: Bone Disease in 2016: Beyond the Basics
|
|
W42: AACE – ABIM Maintenance of Certification and Mini - Board Review Course
|
5:30 pm – 7:45 pm |
WSS1: Hypoparathyroidism: New Treatment Concepts & Guidelines |
5:30 pm – 7:45 pm |
WSS2: Concentrated Insulins: Clinical Applications and Use in Practice Settings |
THURSDAY, MAY 26 |
|
5:15 am – 7:30 am |
TSS1: LDL-C Reduction in the Patient with Diabetes: How Low Should We Go and How Should We Get There? |
6:30 am – 6:30 pm |
Registration |
7:00 am – 6:00 pm |
CME Station Hours |
9:45 am -2:15 pm |
Exhibit Hall Hours |
8:00 am – 8:30 am |
General Session Announcements |
8:30 am – 9:15 am |
TGS1: Diabetes and the Microbiome Room: Panzacola F/G |
9:15 am – 10:00 am |
TGS2: Metabolomics for the Clinician: Implications for the Treatment of Metabolic Disease Room: Panzacola F/G |
10:00 am – 11:00 am |
Young Investigator Poster Session in Exhibit Hall |
10:15 am – 11:00 am |
Product Theaters in the Exhibit Hall |
11:15 am – 12:00 pm |
TGS3: Co-Evolution of Scientific Disciplines and Therapies for Disorders of Lipid Metabolism Room: Panzacola F/G |
12:00 pm – 1:00 pm |
Boxed Lunch in Exhibit Hall |
12:00 pm – 12:45 pm |
Young Investigator ePoster Oral Presentations |
12:30 pm – 2:15 pm |
Women of Endocrinology Luncheon Moderator: Etie S. Moghissi, MD |
1:00 pm – 1:45 pm |
Product Theater in the Exhibit Hall |
1:15pm – 2:00 pm |
Product Theaters in the Exhibit Hall |
2:15 pm – 3:15 pm |
MEET-THE-EXPERTS SESSION I |
|
T11: The D-Lightful Vitamin D for Health: Truths and Myths Room: Suwannee 16/17 |
|
T21: How to Initiate Treatment for Type 2 Diabetes Mellitus: One agent at a Time Versus Combination Therapy |
|
T31: Mild Hypercortisolism Due to Adrenal Adenoma – Is It Really “Subclinical?” Room: Suwannee 13/14 |
T41: How Low Should You Go: Lipid Management in the PCSK9 Era Room: St. John's 24/25 |
|
T51: Endocrine Hypertension in 2016: Making the Diagnosis Room: St. John's 28/29 |
|
T61: Pediatric Endocrinology: Optimizing Growth Handout:2 Room: Suwannee 20/21 |
|
T71: Practical Strategies for Management of the Pseudo-Endocrine Patient Room: Suwannee 18/19 |
|
3:15 pm – 3:30 pm | Coffee Break |
3:30 pm – 4:30 pm | MEET-THE-EXPERTS SESSION II |
T12: Options for Treatment of Hypogonadism in Men Desiring Fertility Preservation Room: Suwannee 15 |
|
T22: Point/Counterpoint: Radioactive Iodine in Papillary Thyroid Cancer: To Use or Not to Use…That Is the Question Room: Suwannee 16/17 |
|
T32: Is Insulin Therapy Inevitable in the Management of Diabetes? Room: Suwannee 20/21 |
|
T42: Mild Hypercortisolism Due to Adrenal Adenoma – Is It Really “Subclinical?” Room: Suwannee 13/14 |
|
T52: How Low Should You Go: Lipid Management in the PCSK9 Era Room: St. John's 24/25 |
|
T62: Endocrine Hypertension in 2016: Making the Diagnosis Room: St. John's 28/29 |
|
T72: Practical Strategies for Management of the Pseudo-Endocrine Patient Room: Suwannee 18/19 |
|
4:30 pm – 4:45 pm | Break |
4:45 pm – 5:45 pm | MEET-THE-EXPERTS SESSION III |
T13: The D-Lightful Vitamin D for Health: Truths and Myths Room: St. John's 24/25 |
|
T23: How to Initiate Treatment for Type 2 Diabetes Mellitus: One agent at a Time versus Combination Therapy Room: Suwannee 11/12 |
|
T33: Pediatric Endocrinology: Optimizing Growth Room: Suwannee 18/19 |
|
T43: Options for Treatment of Hypogonadism in Men Desiring Fertility Preservation Room: Suwannee 15 |
|
T53: Point/Counterpoint: Radioactive Iodine in Papillary Thyroid Cancer: To Use or Not to Use…That is the Question Room: Suwannee 16/17 |
|
T63: Is Insulin Therapy Inevitable in Management of Diabetes? Room: Suwannee 20/21 |
|
T73: History of Diabetes Mellitus: 1500 B.C. to Present Room: Suwannee 13/14 |
|
6:00 pm – 7:00 pm | Domestic & International Chapter Receptions |
7:15 pm – 9:30 pm | TSS3: Balancing the Evidence: Considering the Clinical Impact of Newer Antihyperglycemic Agents for the Treatment of Type 2 Diabetes Room: Panzacola H 3/4 |
TSS4: Patient Centered Care of the Patient with Obesity Room: Panzacola H 1/2 |
FRIDAY, MAY 27 |
|
5:15am – 7:30 am |
FSS1: Keeping Pace with CGM Technology: The Path to Successful Implementation |
7:30am – 6:30 pm |
Registration |
7:30am – 6:30 pm |
CME Station Hours |
9:45am – 2:15 pm |
Exhibit Hall Hours |
8:00am – 8:20 am |
General Session Announcements |
8:20am – 9:05 am |
FGS1:Pheochromocytoma: Then and Now - A 90-Year Journey Room: Panzacola F/G |
9:15am – 12:00 pm |
IN-DEPTH SYMPOSIA SESSION I |
|
F11: Thryoid Cancer Update
Room: Panzacola H 3/4 |
|
F21: Endocrine Disorders during Pregnancy
Room: Suwannee 13/14 |
|
F31: AACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity
Room: St. John's 24/25 |
|
F41: Diabetes Update 2016
|
|
F51: Practical Clinical Guide to Endocrine Diseases for Nurse Practitioners/ Physician Assistants
|
|
F61: Novel Developments in Diabetes Technology (Non-CME)
Room: Suwannee 18/19 |
12:00pm – 2:15 pm |
Exhibit Hall Break |
12:00pm – 1:00 pm |
Boxed Lunch in Exhibit Hall |
12:00pm – 12:45 pm |
ePoster Oral Presentations |
12:30pm – 2:15 pm |
FIT Luncheon |
1:00pm – 1:45 pm |
Product Theater in the Exhibit Hall |
1:15pm– 2:00 pm |
Product Theaters in the Exhibit Hall |
2:15pm – 5:00 pm |
IN-DEPTH SYMPOSIASESSION II |
|
F12: A Tributeto Saul Hertz: 75th Anniversary of the Use of Radioactive Iodine
Room: Suwannee 15 |
|
F22: TransgenderMedicine: What an Endocrinologist Should Know
Room: Suwannee 11/12 |
|
F32: Endocrinology and Aging, or, “The Taper”
Room: Panzacola H 3/4 |
|
F42: Neuroendocrine Tumor (NET) Syndromes
Room: Suwannee 16/17 |
|
F52: 8th AACE/SMNE Joint Session: Reflections and Future Directions in Endocrinology
Room: Suwannee 18/19 |
|
F62: The Future of Endocrinology Reimbursement
Room: Suwannee 20/21 |
5:00pm – 6:15 pm |
Poster Session in Exhibit Hall |
5:00pm – 6:30 pm |
Wine & Cheese Reception in Exhibit Hall |
6:15pm – 7:00 pm |
Product Theaters in the Exhibit Hall |
7:00pm – 9:15 pm |
FSS3: Basal Insulin 4.0: Updating Your Clinical Practice with Ultralong-acting Insulins Room: Panzacola H 1/2 |
7:00pm – 9:15 pm |
FSS4: Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options Room: Panzacola H 3/4 |
SATURDAY, MAY 28 |
|
7:30am – 5:00 pm |
Registration |
7:00am – 6:00 pm |
CME Station Hours |
9:45am -2:15 pm |
Exhibit Hall Hours |
8:00am – 8:15 am |
Award Presentations |
8:15am – 9:00 am |
SGS1: The Role of Molecular Markers in Thyroid Nodule Management: Then and Now |
9:00am – 9:15 am |
Award Presentations |
9:15am – 10:00 am |
SGS2: The Obesity Epidemic, A Public Health Emergency? |
|
SGS3: Select Abstract Oral Presentations I THE PREVALENCE OF FASTING-EVOKED EN-ROUTE HYPOGLYCEMIA IN DIABETES (FEEHD) IN CLINICAL PRACTICE: A PILOTSURVEY CONTEMPLATING AN ADDITIONAL ORAL AGENTFOR YOUR PATIENT WITH TYPE 2 DIABETES? CONSIDER POSSIBLE INTERACTION BETWEENQUALITY OF YOUR CONVERSATION WITH PATIENT’S ATTEMPTS AT BARGAINING ANDSELF-REPORTED OUTCOMES - LESSONS FROM THE INTRODIA™ STUDY A RANDOMIZED CONTROL TRIAL ON REDUCTIONOF HEMOGLOBIN A1C USING CELL PHONES, COMMUNITY HEALTH WORKERS OR COMBINATIONOF BOTH IN A DISTRICT OF COLUMBIA AFRICAN AMERICAN POPULATION Room: Panzacola H 1/2 |
|
SGS4: Select Abstract Oral Presentations II SYSTEMATIC REVIEW OF THE POSITIVE PREDICTIVE VALUE OF RAS MUTATIONSIN CYTOLOGICALLY INDETERMINATE THYROID NODULES RADIO FREQUENCY ABLATION: AN INNOVATIVE TREATMENT FORADRENAL NEOPLASMS USE OF A DIGITAL HEALTH OFFERING TO OPTIMIZE STATIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES Room: Panzacola H 3/4 |
10:00am – 11:00 am |
Late Breaking Poster Session in Exhibit Hall |
10:15am – 11:00 am |
Product Theaters in the Exhibit Hall |
11:00am – 11:15 am |
Award Presentations |
11:15am – 12:00 pm |
SGS5: Osteoporosis Drugs: Then and Now Room: Panzacola F/G |
11:15am – 12:15 pm |
SGS6: Late Breaking Oral Presentations (Non-CME) Room: Panzacola H 1/2 |
12:15pm – 2:00 pm |
AACE Annual Business Meeting Luncheon |
2:15pm – 3:15 pm |
MEET-THE-EXPERTS SESSION I |
|
S11: Treatment of Severe Pediatric Obesity Room: Suwannee 20/21 |
|
S21: Update on the Evaluation and Treatment of Paget’s Disease Room: St. John's 28/29 |
|
S31: Hormonal Treatment of Menopausal Women: What Are the Data Telling Us (and Not Telling Us?) Room: Suwannee 16/17 |
|
S41: Diagnosis and Management of Anabolic Steroid Abuse Slides PDF Room: Suwannee 15 |
|
S51: Improving the Long-Term Management of Benign Thyroid Nodules Room: St John's 24/25 |
|
S61: Active Surveillance Versus Surgery in Low-Risk Thyroid Cancer Room: Suwannee 13/14 |
|
S71: Hyponatremia: Clinical Conundrums in Diagnosis and Treatment Room: Suwannee 11/12 |
|
S81: Approach to the Transgender Adolescent: The Evaluation Room: Suwannee 18/19 |
3:15pm– 3:30pm |
Coffee Break |
3:30pm – 4:30 pm |
MEET-THE-EXPERTS SESSION II |
|
S12: Challenging Pituitary Cases Room: Suwannee 16/17 |
|
S22: Emerging Therapies for Treatment of Hypoparathyroidism Room: Suwanee 20/21 |
|
S32: Approach to the Transgender Adolescent: A Case Study of the Jennings Family |
|
S42: Active Surveillance Versus Surgery in Low-Risk Thyroid Cancer Room: Suwannee 13/14 |
|
S52: Diagnosis and Management of Anabolic Steroid Abuse Slides PDF Room: Suwannee 15 |
|
S62: Improving the Long-Term Management of Benign Thyroid Nodules |
|
S72: Osteoporosis Drug Holidays: Why, When and What's After Room: St. John's 28/29 |
|
S82: Hyponatremia: Clinical Conundrums in Diagnosis and Treatment Room: Suwannee 11/12 |
4:30pm – 4:45 pm |
Break |
4:45pm – 5:45 pm |
MEET-THE-EXPERTS SESSION III |
|
S13: Treatmentof Severe Pediatric Obesity Room: Suwannee 15 |
|
S23: Hormonal Treatment of Menopausal Women: What Are the Data Telling Us (and Not Telling Us?) Room: St. John's 24/25 |
|
S33: Update on the Evaluation and Treatment of Paget’s Disease Room: Suwannee 11/12 |
|
S43: Challenging Pituitary Cases Room: Suwannee 16/17 |
|
S53: Osteoporosis - Drug Holidays: Why, When and What's After Room: St. John's 28/29 |
|
S63: Emerging Therapies for Treatment of Hypoparathyroidism Room: Suwannee 20/21 |
|
S73: Medicine After the Holocaust Room: Suwannee 13/14 |
|
S83: Approach to the Transgender Adolescent: A Case Study of the Jennings Family Room: Suwannee 18/19 |
6:30pm |
ACE Convocation |
7:30pm |
President’s Gala |
SUNDAY, MAY 29 |
|
7:00 am – 11:00 am |
Registration |
7:00 am - 8:00 am |
Attendee Breakfast |
7:30 am – 12:00 pm |
CME Station Hours |
8:00 am – 8:15 am |
General Session Announcements |
8:15 am – 8:45 am |
SGS8: Controversies in the Approach to Adrenal Nodules Room: Panzacola F/G |
8:45 am – 9:30 am |
SGS9: The Mystery of the Hidden Parathyroid Adenoma Room: Panzacola F/G |
9:30 am – 9:45 am |
Coffee Break |
9:45 am – 11:00 am |
SGS7: Dilemmas in Thyroid Cancer: Endocrine/Surgical Consensus Room: Panzacola F/G |
11:00 am – 11:15 am |
Final Announcements; Adjournment |
The Program Committee of the American Association of Clinical Endocrinologists (AACE), composed of physician experts, consistently strives to monitor issues and trends in the diverse areas of endocrinology. Its mission is to continually help AACE members enhance and update their knowledge so that they can provide the highest-quality care to patients.
The physician experts presenting at the Annual Scientific and Clinical Congress deliver programs designed to highlight the importance of the endocrinologist’s role in the intervention and treatment of endocrine-related diseases. Scientific, technological, economic, social, and political factors are presented so that endocrinologists are informed about the latest scientific advances and treatment modalities.
The topics and educational objectives for the 2016 program were developed from a wide variety of sources, including the Program Committee, expert and clinical advisor opinions, and literature reviews about current challenges in healthcare. Educational needs were also identified by attendees at the 2015 AACE Annual Scientific and Clinical Congress, utilizing outcome measurements focused on increasing participants’ knowledge and skills in key topics related to endocrinology. These included both quantitative and qualitative evaluations used for each accredited CME activity.
Based on these findings, the following topics were identified as being future educational needs of the AACE membership:
All physicians and allied health professionals interested in the study, diagnosis, and treatment of endocrine-related diseases.